Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 29% ± 11% | |
type II pneumocyte | 4 studies | 21% ± 5% | |
glutamatergic neuron | 4 studies | 33% ± 14% | |
GABAergic neuron | 3 studies | 28% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1514.86 | 244 / 245 | 99% | 17.83 | 497 / 502 |
pancreas | 100% | 1162.67 | 328 / 328 | 98% | 14.63 | 174 / 178 |
kidney | 100% | 1084.70 | 89 / 89 | 97% | 25.52 | 878 / 901 |
esophagus | 100% | 1817.52 | 1443 / 1445 | 97% | 18.76 | 178 / 183 |
skin | 100% | 1745.20 | 1805 / 1809 | 97% | 28.08 | 457 / 472 |
thymus | 100% | 2594.09 | 653 / 653 | 97% | 27.39 | 584 / 605 |
lung | 100% | 1444.58 | 577 / 578 | 95% | 18.08 | 1094 / 1155 |
ovary | 100% | 1946.99 | 180 / 180 | 94% | 11.77 | 406 / 430 |
liver | 100% | 1303.09 | 226 / 226 | 93% | 18.55 | 378 / 406 |
brain | 93% | 699.45 | 2469 / 2642 | 99% | 12.55 | 696 / 705 |
bladder | 100% | 2292.29 | 21 / 21 | 91% | 21.46 | 461 / 504 |
uterus | 100% | 2166.68 | 170 / 170 | 91% | 15.07 | 417 / 459 |
stomach | 100% | 970.61 | 358 / 359 | 90% | 13.43 | 257 / 286 |
breast | 100% | 1366.21 | 459 / 459 | 89% | 29.75 | 992 / 1118 |
adrenal gland | 100% | 2273.89 | 258 / 258 | 88% | 12.01 | 202 / 230 |
intestine | 100% | 1933.01 | 965 / 966 | 86% | 12.82 | 455 / 527 |
adipose | 100% | 1603.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1226.78 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.64 | 1 / 1 |
blood vessel | 100% | 1169.64 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1069.76 | 798 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 13.86 | 43 / 45 |
heart | 94% | 740.63 | 807 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 13.87 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 66% | 8.68 | 53 / 80 |
peripheral blood | 49% | 608.62 | 456 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0045780 | Biological process | positive regulation of bone resorption |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
Gene name | TMEM64 |
Protein name | Transmembrane protein 64 |
Synonyms | hCG_32991 |
Description | FUNCTION: Positively regulates TNFSF11-induced osteoclast differentiation. Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with SERCA2 which is critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS generation necessary for proper osteoclast generation. Association between TMEM64 and SERCA2 in the ER leads to cytosolic Ca (2+) spiking for activation of NFATC1 and production of mitochondrial ROS, thereby triggering Ca (2+) signaling cascades that promote osteoclast differentiation and activation. Negatively regulates osteoblast differentiation and positively regulates adipocyte differentiation via modulation of the canonical Wnt signaling pathway. Mediates the switch in lineage commitment to osteogenesis rather than to adipogenesis in mesenchymal stem cells by negatively regulating the expression, activity and nuclear localization of CTNNB1. . |
Accessions | B3KW24 ENST00000422900.1 ENST00000418210.2 [Q6YI46-4] E5RIS8 H0Y6S7 ENST00000458549.7 [Q6YI46-1] ENST00000521852.5 ENST00000519519.5 [Q6YI46-2] Q6YI46 |